Literature DB >> 21271480

[Acute kidney injury].

T Feldkamp1, A Bienholz, A Kribben.   

Abstract

New guidelines of the "Kidney Disease: Improving Global Outcome" (KDIGO) working group standardize the definition of acute kidney injury (AKI) and acute kidney disease (AKD) allowing the assessment of prognosis and efficacy of prophylactic and therapeutic measures in different patient cohorts. The degree of severity and the duration of acute kidney injury are critical factors for the development of chronic kidney disease and mortality. The achievement of optimal fluid volumes is a cornerstone in the treatment during the early phase of AKI, while volume overload should be avoided in the late phase of established AKI. Recently employed biomarkers are promising for the early detection and prognosis of AKI, but cannot yet be used as routine tests. Microscopic urinalysis, a very old and cost-effective diagnostic measure, provides valuable informations about the severity and the course of AKI. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271480     DOI: 10.1055/s-0031-1272508

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments.

Authors:  Patrick M Honore; Rita Jacobs; Olivier Joannes-Boyau; Jouke De Regt; Willem Boer; Elisabeth De Waele; Vincent Collin; Herbert D Spapen
Journal:  Ann Intensive Care       Date:  2011-08-09       Impact factor: 6.925

2.  Standard operating procedures for antibiotic therapy and the occurrence of acute kidney injury: a prospective, clinical, non-interventional, observational study.

Authors:  Irit Nachtigall; Sascha Tafelski; Karsten Günzel; Alexander Uhrig; Robert Powollik; Andrey Tamarkin; Klaus D Wernecke; Claudia Spies
Journal:  Crit Care       Date:  2014-06-12       Impact factor: 9.097

3.  Prognosis of AKI in malignant diseases with and without sepsis.

Authors:  Malte Heeg; Alexander Mertens; David Ellenberger; Gerhard A Müller; Daniel Patschan
Journal:  BMC Anesthesiol       Date:  2013-10-29       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.